Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
CT
Digital X-Ray
Interventional
Molecular Imaging
MRI
Radiation Oncology/Therapy
Ultrasound
Womens Imaging
Molecular Imaging
Bayer issues positive report for cardiac amyloidosis radiotracer
By
AuntMinnie.com staff writers
I-124 evuzamitide met its primary endpoints, according to Bayer.
May 7, 2026
PSMA-PET linked to higher use of systemic therapies
By
Will Morton
ARPI therapy was initiated in 15.6% of PSMA-PET patients versus 7.7% of bone scan patients.
May 7, 2026
Eden Radioisotopes files NRC permit for isotope production complex
By
AuntMinnie.com staff writers
The company said the facility is designed to produce up to 50% of global demand for molybdenum-99 (Mo-99).
May 6, 2026
Chinese scientists develop wearable brain PET system
By
Will Morton
The system could offer new opportunities for brain PET imaging beyond the constraints of conventional static systems.
May 1, 2026
NET tracers first widened, then closed imaging access gap
By
Will Morton
Ga-68 DOTATATE/DOTATOC captured 33.8% market share in its 2017 debut and reached 90.9% by 2020.
April 30, 2026
Serac highlights study on 99mTc-maraciclatide for endometriosis care
By
AuntMinnie.com staff writers
Serac Healthcare is highlighting success from a study that evaluated the company's gamma-emitting radiotracer, 99mTc-maraciclatide.
April 30, 2026
Lu-177 PSMA-SPECT/CT predicts survival in mCRPC
By
Will Morton
Lu-177 PSMA-617 SPECT/CT total tumor volume complete response at six weeks associated with overall survival.
April 29, 2026
PET improves treatment planning for pituitary tumors
By
Will Morton
Ga-68 DOTATATE PET altered radiation treatment volumes by nearly 20% compared with MRI alone.
April 28, 2026
PharmaLogic opens PET radiopharmaceutical facility in Atlanta
By
AuntMinnie.com staff writers
PharmaLogic Holdings has opened a PET radiopharmaceutical manufacturing facility in Atlanta.
April 28, 2026
C-Ray Therapeutics wins FDA active status for Cu-64 drug master file
By
AuntMinnie.com staff writers
C-Ray Therapeutics has received active status from the FDA for its Type II Drug Master File for Cu-64 chloride for radiolabeling.
April 28, 2026
Plus Therapeutics beefs up manufacturing with SpectronRx
By
AuntMinnie.com staff writers
Partnership supports 2026 radiopharmaceutical supply goal.
April 27, 2026
ChatGPT matches nuclear medicine experts on FDG-PET/CT scans
By
Will Morton
Models excelled on cases with well-defined metabolic patterns, such as in typical cases of Alzheimer's disease, yet were less accurate on complex cases.
April 24, 2026
Page 1 of 626
Next Page
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
